2018
DOI: 10.1152/ajpheart.00121.2018
|View full text |Cite
|
Sign up to set email alerts
|

PTEN inhibitor VO-OHpic attenuates inflammatory M1 macrophages and cardiac remodeling in doxorubicin-induced cardiomyopathy

Abstract: Doxorubicin (Doxo) is an effective agent commonly used in cancer therapeutics. Unfortunately, Doxo treatment can stimulate cardiomyopathy and subsequent heart failure, limiting use of this drug. The role of phosphatase and tensin homolog (PTEN) in apoptosis has been documented in Doxo induced cardiomyopathy (DIC) and heart failure models. However, whether direct inhibition of PTEN attenuates apoptosis, cardiac remodeling, and inflammatory M1 macrophages in DIC model remains elusive. Therefore, the current stud… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
34
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(34 citation statements)
references
References 59 publications
(90 reference statements)
0
34
0
Order By: Relevance
“…Chemotherapy has been shown to mitigate the in ammatory response with exercise (53,64), induce leukopenia/cytopenia (19), and disrupt cardiacmacrophage in ltration (65). To the best of our knowledge, this is the rst study to demonstrate that chemotherapeutic 5FU has deleterious effects on immune cell abundance in otherwise healthy uninjured skeletal muscle.…”
Section: Discussionmentioning
confidence: 82%
“…Chemotherapy has been shown to mitigate the in ammatory response with exercise (53,64), induce leukopenia/cytopenia (19), and disrupt cardiacmacrophage in ltration (65). To the best of our knowledge, this is the rst study to demonstrate that chemotherapeutic 5FU has deleterious effects on immune cell abundance in otherwise healthy uninjured skeletal muscle.…”
Section: Discussionmentioning
confidence: 82%
“…In another study, Hadi et al reported that treatment with vitamin E and telmisartan significantly reduces infiltration of monocytes into the heart, thereby reducing the cardiac inflammatory response, relieving DOX-induced cardiac injury and improving cardiac dysfunction [ 37 ]. We and other researchers have reported that DOX treatment promotes imbalance between M1 macrophages and M2 macrophages in mice, and aggravation of this imbalance further aggravates cardiac injury and cardiomyocyte apoptosis [ 7 , 38 ]. These results suggest that DOX-induced immune cell activation plays an important role in myocardial injury.…”
Section: Discussionmentioning
confidence: 99%
“…Further evidences demonstrate that a potent inhibitor of PTEN, VO-OHpic, inhibits adverse cardiac remodeling due to the macrophages polarization. Pro-inflammatory M1 macrophages are reduced while anti-inflammatory M2 macrophages are increased in animal models treated with doxorubicin which unfortunately can stimulate cardiomyopathy [94].…”
Section: Role Of Pten In Macrophages Functionmentioning
confidence: 99%